We are pleased to announce that the 2nd pilot rapid assessment of JA2 WP5 Strand B on ‘Renal denervation systems for treatment-resistant hypertension’ is now available.
With best wishes for a productive and successful 2014, EUnetHTA is happy to share the following brief review of main achievements in the JA2 first year. We hope to see you in Rome on October 30-31 2014 to share the results of Year 2 in person at the EUnetHTA conference HTA 2.0 Europe – Teaming up for Value!
SEED - the Shaping European Early Dialogues Consortium – led by the French Haute Autorité de Santé and financed by a European Commission call for tender - was set up to explore various scenarios for conducting early dialogues (EDs) between health technology assessors and healthcare product developers during the development phase of medicinal products and medical devices.
We are happy to present a renewed version of the HTA Core Model® - Version 2.0!
Today, EMA and EUnetHTA publish a joint 3-year work plan.